ng cells from COVID-19 patients, said lead authors Dr. Behdad (Ben) Afzali, chief of the Immunoregulation Section of the NIHs National Institute of Diabetes and Digestive and Kidney Diseases, and Dr. Majid Kazemian, assistant professor of biochemistry and computer science at Purdue University.